Equillium (EQ) Return on Capital Employed Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - | 4,748.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,748.00 |
| Dec 31, 2025 | -872.00 |
| Sep 30, 2025 | -6,251.00 |
| Jun 30, 2025 | -14,647.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 5,056.00 |
| Sep 30, 2024 | 770.00 |
| Jun 30, 2024 | 504.00 |
| Mar 31, 2024 | 1,384.00 |
| Dec 31, 2023 | 13,975.00 |
| Sep 30, 2023 | 15,119.00 |
| Jun 30, 2023 | 8,662.00 |
| Mar 31, 2023 | 3,260.00 |
| Dec 31, 2022 | -14,992.00 |
| Sep 30, 2022 | -14,226.00 |
| Jun 30, 2022 | -10,021.00 |
| Mar 31, 2022 | -6,486.00 |
| Dec 31, 2021 | -1,104.00 |
| Sep 30, 2021 | 347.00 |
| Jun 30, 2021 | 3,051.00 |
| Mar 31, 2021 | 2,207.00 |
| Dec 31, 2020 | 1,207.00 |
| Sep 30, 2020 | -308.00 |
| Jun 30, 2020 | -3,012.00 |
| Mar 31, 2020 | -3,428.00 |
| Dec 31, 2019 | -2,348.00 |